Markets › United States › NAS › CRBU

Caribou Biosciences Inc

NAS:CRBUHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$0.5751+2.70%LiveIn session · ≈ AED 2.11 · Market cap $61.66M · Next earnings Tue 10 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−178.5%	89.7%	73.7%	89.8%	60.7%	67.3%	—	—
Operating margin	−292.2%	−697.8%	−768.2%	−336.6%	−1,667.2%	−1,220.5%	−1,220.5%	+0.0 pts
Net margin	−277.6%	−697.3%	−717.8%	−296.1%	−1,491.9%	−1,327.4%	−1,327.4%	+0.0 pts
EBITDA margin	−284.8%	−683.6%	−691.0%	−285.3%	−1,452.7%	−1,299.7%	—	—
Return on equity	146.4%	−17.3%	−33.0%	−27.7%	−58.9%	−121.2%	−121.2%	+0.0 pts
Return on assets	−95.2%	−15.1%	−26.6%	−23.6%	−47.6%	−84.5%	−84.5%	+0.0 pts
Return on capital employed	−152.7%	−16.1%	−30.8%	−28.7%	−58.9%	−90.8%	—	—
Debt / equity	−0.1×	0.0×	0.1×	0.1×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	4.4%	0.1%	7.4%	6.3%	8.5%	15.5%	—	—
Interest coverage	−1,806.2×	−8,372.4×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	2.0×	15.1×	9.3×	12.0×	7.2×	5.7×	5.7×	+0.0%
Quick ratio	2.0×	15.1×	9.3×	12.0×	7.2×	5.7×	—	—
Cash ratio	1.3×	9.3×	2.1×	1.8×	0.5×	0.5×	0.5×	+0.0%
Asset turnover	0.3×	0.0×	0.0×	0.1×	0.0×	0.1×	—	—
Receivables turnover	2.4×	1.2×	3.0×	8.9×	3.1×	3.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—